2024 NAPBC Standards: How MagView Supports New Risk Assessment Requirements
The 2024 NAPBC Standards are now in effect! These new standards from the National Accreditation Program for Breast Centers (NAPBC) focus on the patient care continuum “from screening and prevention, to diagnosis, treatment, and survivorship,” emphasizing the provision of “value-based care with multidisciplinary support.” Effective January 1, 2024, the new standards require breast centers to […]
Radiologists and Risk Assessment: Employing the Tyrer-Cuzick Score in the Reporting Workflow
In the U.S., approximately 1 in 8 women can expect to get breast cancer sometime during their lives. Since early detection is such a critical weapon in the fight against breast cancer, risk assessment is essential to help identify women who can benefit from more intensive breast cancer surveillance. Using breast cancer risk assessment models such as Tyrer-Cuzick in […]
Webinar Summary: Breast Imaging in the Era of Personalized Care: Tools, Tactics, and Triumphs in Risk Assessment
Breast cancer risk assessment is essential for identifying women who can benefit from more intensive breast cancer surveillance. In our recent webinar, “Breast Imaging in the Era of Personalized Care: Tools, Tactics, and Triumphs in Risk Assessment,” Dr. Stacy Smith-Foley, the Medical Director of The Breast Center at CARTI, discussed: The importance of risk assessment […]
MagView Introduces a Stand-Alone Software for High-Risk Breast Cancer Screening
Fulton, MD – November 20, 2023 – MagView, a leading healthcare solutions provider, introduces Luminary Risk, an advanced software that enhances high-risk breast screening programs. Recognizing the importance of early detection and personalized care, MagView has launched Luminary Risk, as a dedicated software solution that expands the capabilities of high-risk breast screening programs with advanced […]
Webinar: Breast Imaging in the Era of Personalized Care: Tools, Tactics, and Triumphs in Risk Assessment
THIS WEBINAR HAS CONCLUDED. To request access to the on-demand recording, EMAIL sales@magview.com. In U.S. breast cancer is the most commonly diagnosed cancer. In fact, approximately 1 in 8 women in this country can expect to get it sometime during their lives. Since early detection is the best weapon in the fight against breast cancer, effective risk […]
Risk Assessment for Breast Cancer: ACR Recommends Women Have Their Breast Cancer Risk Assessed by Age 25
When it comes to risk assessment for breast cancer, many experts underscore the importance of screening early enough and often enough using the most appropriate screening modality. In a recent update to its breast cancer screening recommendations, the American College of Radiology® (ACR®) now recommends that women have their breast cancer risk assessed by age […]
How Breast Centers Incorporate Tyrer-Cuzick in Mammogram Reports and Lay Letters
Using breast cancer risk assessment models—such as Tyrer-Cuzick—supports risk assessment, which has become best practice in breast screening. This approach helps identify patients who can benefit from personalized screening and helps breast imaging centers drive downstream revenue—such as breast MRI and genetic counseling/testing services. Although there are various models available, the Tyrer-Cuzick v8.0 (IBIS) is […]
Genetic Testing for Breast Cancer: How to Best Incorporate it into Your Imaging Workflow
Understanding a patient’s genetics plays an integral role in being able to assess their comprehensive risk for breast cancer. That’s why MagView has incorporated genetic risk factors into its breast cancer risk assessment software and created an easy way for breast centers to integrate genetic testing into their organization’s workflow. The Role of Genetics in […]
Breast Cancer Risk Assessment Software: The Benefits of Integrated Solutions
The importance of breast cancer screening solutions for high-risk patients is demonstrated by statistics that underscore the prevalence of this type of cancer. Breast cancer is currently the most commonly diagnosed cancer in U.S. women and is the second leading cause of cancer death in this demographic. In 2022, breast cancer is expected to account […]
Why Tyrer-Cuzick is the Breast Cancer Risk Model of Choice
Personalized breast cancer care is making rapid progress—and breast cancer risk assessment plays an increasingly critical role in support of prevention, early detection, and effective treatment. There are various breast cancer risk assessment models available, and the Tyrer-Cuzick v8.0 (IBIS) is one of the most reliable tools breast centers can use to identify high-risk patients. What […]